Rheumatoid Arthritis Clinical Trials in Philadelphia

Showing 521-540 of 3,347 trials

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

NCT07219407

This is a clinical research study for an investigational drug called RAP-219 in patients with Refractory Focal Epilepsy. This study is being conducted to determine RAP-219 Long- term safety and open-label antiseizure activity in patients with Refractory Focal Epilepsy.

Focal EpilepsyEpilepsyRefractory Focal Epilepsy+3 more

Rapport Therapeutics Inc.30 participantsStarted Dec 2025

Boise, Idaho, United States • Rochester, Minnesota, United States • New York, New York, United States +4 more locations

RECRUITING< 1 mile

Longitudinal Study for Central Nervous System Vasculitis

NCT05734404

Primary central nervous system vasculitis (CNSV) is a potentially fatal, single-organ vasculitis that often involves a spectrum of neurologic complications, including strokes, cognitive and speech impairment, visual loss, dementia, and encephalopathy. The purpose of this study is to establish a research cohort to investigate the disease process, treatments, and patient outcomes in CNSV.

Central Nervous System VasculitisCNS VasculitisCNSV+1 more

University of Pennsylvania40 participantsStarted Mar 2023

Rochester, Minnesota, United States • Cleveland, Ohio, United States • Philadelphia, Pennsylvania, United States +3 more locations

RECRUITINGPhase 2< 1 mile

A Randomized Multicenter Study for Isolated Skin Vasculitis

NCT02939573

Multi-center sequential multiple assignment randomized trial comparing the effectiveness of three different standard of care treatment options for patients with isolated skin vasculitis.

Primary Cutaneous VasculitisCutaneous Polyarteritis NodosaIgA Vasculitis+1 more

University of Pennsylvania90 participantsStarted Jan 2017

Kansas City, Kansas, United States • Boston, Massachusetts, United States • Rochester, Minnesota, United States +13 more locations

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

Longitudinal Study for Central Nervous System Vasculitis

A Randomized Multicenter Study for Isolated Skin Vasculitis

Rheumatoid Arthritis Trials in Other Cities

Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

One-Time DNA Study for Vasculitis

US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair

Short Course Radiotherapy

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

Expanded Access Protocol: Umbilical Cord Blood Infusions for Children With Brain Injuries

An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia.

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18

Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis

Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Learning Study: Improving Vision in Adults With Macular Degeneration

Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML

A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors

Other Conditions in Philadelphia